Indication

Proteus pneumonia

Proteus pneumonia is a bacterial lower respiratory tract infection of the lung parenchyma caused by members of the Gram-negative genus *Proteus*, most commonly *Proteus mirabilis*. Read more about Proteus pneumonia

174 drugs 86 manufacturers

Advertisement

Drugs that treat it

Common Proteus pneumonia therapies.

Showing 28–36 of 174 drugs

Filter & compare in the drug finder →Opens the drug finder with Proteus pneumonia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Proteus pneumonia.

Proteus pneumonia is a bacterial lower respiratory tract infection of the lung parenchyma caused by members of the Gram-negative genus *Proteus*, most commonly *Proteus mirabilis*.

It predominantly affects hospitalized, debilitated, or immunocompromised patients, particularly older adults, individuals with chronic pulmonary or neurological diseases, and those prone to microaspiration or requiring mechanical ventilation.

Pathophysiologically, the organism colonizes the respiratory tract via aspiration of oropharyngeal secretions or hematogenous seeding from an extrapulmonary site, such as an infected urinary tract.

The infection typically manifests with fever, productive cough, dyspnea, hypoxemia, and pulmonary consolidation on chest radiography, with severe presentations potentially complicated by necrotizing tissue damage, abscess formation, or systemic bacteremia.

Personalize your experience

Follow Proteus pneumonia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it